**
Recent investigations have unveiled a concerning reality regarding the exposure of fetuses to per- and polyfluoroalkyl substances (PFAS), commonly referred to as “forever chemicals.” A pioneering study conducted by Mount Sinai researchers suggests that the levels of these hazardous compounds in umbilical cord blood are significantly higher than previously acknowledged. This revelation raises urgent questions about the health implications for newborns and the effectiveness of regulatory measures in place.
Unprecedented Findings in Umbilical Cord Blood
Traditionally, analyses of umbilical cord blood have concentrated on a limited selection of PFAS compounds, primarily perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS). However, this latest research encompasses a much broader scope, examining 120 samples that had previously identified only a handful of these substances. The study employed a “non-targeted analysis” methodology, uncovering a staggering total of 42 distinct PFAS compounds across the samples tested.
Shelley Liu, an associate professor at the Icahn School of Medicine at Mount Sinai and co-author of the study, emphasised the significance of these findings: “Babies are exposed to many more PFAS than we previously thought. It’s particularly important to understand because it is a very vulnerable period when fetuses are exposed.”
The Dangers of PFAS
PFAS, a group comprising approximately 15,000 different chemicals, are renowned for their water-, stain-, and grease-resistant properties. These substances have been linked to a host of serious health issues, including cancer, birth defects, compromised immune systems, elevated cholesterol levels, and kidney disease. Their persistent nature in the environment has earned them the moniker “forever chemicals,” as they do not decompose naturally.
Research has consistently demonstrated that fetal exposure to PFAS can lead to detrimental health outcomes. A comprehensive review of 40 studies found these chemicals present in 30,000 umbilical cord blood samples. Connections have been drawn between elevated maternal PFAS levels and adverse effects, such as increased infant mortality rates, low birth weights, and potential obesity later in life. Furthermore, fetal exposure has been associated with heightened risks for cancer, neurological disorders, and cardiovascular diseases in later years.
Inadequate Regulatory Oversight
The legacy compounds PFOA and PFOS were widely used until relatively recently but have since been phased out in favour of newer PFAS variants, which manufacturers often claim are less harmful—though such assertions frequently lack robust evidence. Alarmingly, the methods employed by regulatory bodies to monitor these substances have not kept pace with the rapid evolution of PFAS chemistry. For instance, the US Environmental Protection Agency (EPA) typically tests water samples for only about 30 to 40 PFAS compounds, even though independent research has identified thousands in various environments.
The Mount Sinai study highlights a significant disparity in detection methods. By comparing traditional testing with its non-targeted approach, the researchers consistently found greater levels of PFAS contamination. Liu pointed out that while the EPA has recently approved a blood test capable of detecting 53 compounds, the Mount Sinai analysis identified 31 additional compounds absent from the EPA’s testing list.
Implications for Infant Health
While the Mount Sinai study did not delve into specific health outcomes linked to the elevated PFAS levels, Liu acknowledged the general correlation between higher blood concentrations of these chemicals and an increased risk of health complications. The blood samples analysed were part of the federal government’s Home Study, which tracks PFAS exposure and health repercussions over time. The Mount Sinai team plans to further investigate the health implications of these findings.
David Andrews, acting chief science officer at the Environmental Working Group, an independent nonprofit organisation, remarked on the study’s significance: “This paper is a stark reminder of the importance of health-protective regulations and how lax oversight can result in babies being born pre-polluted with harmful chemicals such as PFAS.”
Why it Matters
The implications of this research are profound. As the evidence mounts regarding the pervasive presence of harmful chemicals in the womb, it becomes increasingly crucial for policymakers and health regulators to prioritise stringent measures that protect vulnerable populations, particularly expectant mothers and their children. The findings urge a reevaluation of current testing protocols and regulatory frameworks, spotlighting the urgent need for comprehensive action to mitigate the risks associated with PFAS exposure. Without such measures, we risk perpetuating a cycle of health crises that could impact generations to come.
